 |
|
|
| |
Safety and Tolerability of Direct Acting Antiviral Agents (DAAs)
Used in Usual Clinical Practice: HCV-TARGET International Consortium
|
| |
| |
Reported by Jules Levin
AASLD 2016 Nov 11-15 Boston, MA
Michael W. Fried, K. Rajender Reddy, Mitchell L. Shiffman, Stefan Zeuzem, Norah Terrault, Alexander Kuo, Paul J. Pockros, Mark S. Sulkowski, Michael P. Manns, Jacqueline G. O'Leary, Lucy Akushevich, Monika Vainorius, David R. Nelson, Joseph K. Lim
|
| |
|
|
|
|
|
